Immune response during tumor therapy with antibody-superantigen fusion proteins

International Journal of Cancer

Volumn 68, Issue 1, 1996, Pages 109-113

  Rosendahl, Alexander ^a   Hansson, Johan ^a   Sundstedt, Anette ^a   Kalland, Terje ^a,b   Dohlsten, Mikael ^a,b  

^a Pharmacia & Upjohn AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ENTEROTOXINS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; RECOMBINANT FUSION PROTEINS; SUPERANTIGENS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029854470     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960927)68:1<109::AID-IJC19>3.0.CO;2-6     Document Type: Article

References (32)

1. CARLSSON, R. and SJÖGREN, H.O., Kinetics of IL-2 and interferon-γ production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell. Immunol., 96, 175-183 (1985).
2. CHOI, Y.W., HERMAN, A., GIGUSTO, T., WADE, T., MARRACK, P. and KAPPLER, J., Residues of the variable region of the T cell receptor β-chain that interact with S. areus toxin superantigens. Nature (Lond.), 346, 471-473 (1990).
3. CHOMARAT, P., RISSOAN, M.C., BANCHEREAU, J. and MIOSSEC, P., Interferon γ inhibits interleukin 10 production by monocytes. J. exp. Med., 177, 523-527 (1993).
4. D'ANDREA, A., ASTA-AMEZAGA, M., VALIANTE, N.M., MA, X., KUBIN, M. and TRINCHIERI, G., Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. exp. Med., 178, 1041-1048 (1993).
5. DELLABONA, P., PECCOUD, J., KAPPLER, J., MARRACK, P., BENOIST, C. and MATHIS, D., Superantigens interact with MHC class-II molecules outside of the antigen groove. Cell, 62, 1115-1121 (1990).
6. DE WAAL MALEFYT, R., HAANEN, J.B., SPITS, H., RONCAROLO, M.G., TE VELDE, A., FIGDOR, C.G., JOHNSON, K., KASTELEIN, R., YSSEL., H. and DE VRIES, J.E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. exp. Med., 174, 915-924 (1991).
7. DING, L., LINSLEY, P.S., HUANG, L.H., GERMAIN, R.N. and SHEVANCH, E.M., IL-10 inhibits costimulatory activity by selectively inhibiting the up-regulalion of B7 expression. J. Immunol., 151, 1224-1234 (1993).
8. DOHLSTEN, M., ABRAHMSEN, L., BJORK, P., LANDO, P.A., HEDLUND, G., FORSBERG, G., BRODIN, T., GASCOIGNE, N.R., FORBERG, C., LIND, P. and KALLAND, T., Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy. Proc. nat. Acad. Sci. (Wash.), 91, 8945-8949 (1994).
9. DOHLSTEN, M., HANSSON, J., OHLSSON, L., LITTON, M. and KALLAND, T., Antibody targeted superantigens are potent inducers of tumor infiltrating T lymphocytes in vivo. Proc. nat. Acad. Sci. (Wash.), 92, 9791-9795 (1995).
10. DOHLSTEN, M., LANDO, P.A., HEDLUND, G., TROWSDALE, J. and KALLAND, T., Targeting of human cytotoxic T lymphocytes to MHC class II expressing cells by staphylococcal enterotoxins. Immunology, 71, 96-100 (1990).
11. DONNELLY, R.P., FREEMAN, S.L. and HAYES, M.P., Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes. J. Immunol., 155, 1420-1427 (1995).
12. FISCHER, H., DOHLSTEN, M., ANDERSSON, U., HEDLUND, G., ERICSSON, P., HANSSON, J. and SJÖGREN, H.O., Production of TNF-α and TNF-b by staphylococcal enterotoxin A activated human T cells. J. Immunol., 144, 4663-4669 (1990).
13. FLEISCHER, B. and SCHREZENMEIER, H., T cell stimulation by staphylococcal enterotoxins: clonally variable response and requirement for major histocompatibility complex class-II molecules on accessory or target cells. J. exp. Med., 167, 1697-1707 (1988).
14. HEDLUND, G., DOHLSTEN, M., HERRMANN, T., BUELL, G., LANDO, P.A., SEGRÉN, S., SCHRIMSHER, J., MACDONALD, H.R., SJÖOREN, H.O. and KALLAND, T., A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class-II products but does not activate T cells. J. Immunol., 147, 4082-4085 (1991).
15. HEDLUND, G., DOHLSTEN, M., PETERSON, C. and KALLAND, T., Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells. Cancer Immunol. Immunother, 36, 89-93 (1993).
16. + cells to bacterial superantigens. Europ. J. Immunol., 22, 1935-1938 (1992).
17. IRWIN, M.J., HUDSON, K.R., FRASER, J.D. and GASCOIGNE, N.R., Enterotoxin residues determining T-cell receptor V-beta binding specificity. Nature (Lond.), 359, 841-843 (1992).
18. KANG, S.M., BEVERLY, B., TRAN, A.C., BRORSON, K., SCHWARTZ, R.H. and LENARDO, M.J., Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science (Wash.), 257, 1134-1138 (1992).
19. KAPPLER, J., KOTZIN, B., HERRON, L., GELFAND, E., BIGLER, R.D., BOYSTON, A., CARREL, S., POSNETT, D., CHOI, Y.W. and MARRACK, P., Vβ-specific stimulation of human T cells by staphylococcal toxins. Science (Wash.), 244, 811-813 (1989).
20. KAPPLER, J.W., STAERZ, U., WHITE, J. and MARRACK, P.C., Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature (Lond.), 332, 35-40 (1988).
21. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature (Lond.), 349, 245-248 (1991).
22. 9+ peripheral T cells responding to staphylococcal enterotoxin B in vivo. Europ. J. Immunol., 21, 1963-1966 (1992).
23. MAREEL, M., DRAGONETTI, C., TAVERNIER, J. and FIERS, W., Tumor-selective cytotoxic effects of murine tumor necrosis factor (TNF) and interferon-gamma (IFN-gamma) in organ culture of B16 melanoma cells and heart tissue. Int. J. Cancer, 42, 470-473 (1988).
24. MARRACK, P. and KAPPLER, J., The staphylococcal enterotoxins and their relatives. Science (Wash.), 248, 705-711 (1990).
25. MEHINDATE, K., THIBODEAU, J., DOHLSTEN, M., KALLAND, T., SEKALY, R.P. and MOURAD, W., Cross-linking of major histocompatibility complex class-II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J. exp. Med., 182, 1573-1577 (1995).
26. MIGATA, K. and OCHI, A., The fate of anergic cells in vivo. J. Immunol., 150, 763-770 (1993).
27. SCHERER, M.T., IGNATOWICZ, L., WINSLOW, G.M., KAPPLER, J.W. and MARRACK, P., Superantigens: bacterial and viral proteins that manipulate the immune system. Ann. Rev. Cell Biol., 9, 101-128 (1993).
28. SUNDSTEDT, A., DOHLSTEN, M., HEDLUND, G., HOIDEN, I., BJORKLUND, M. and KALLAND, T., Superantigens anergize cytokine production but not cylotoxicity in vivo. Immunology, 82, 117-125 (1994).
29. + T cells express perturbed AP-1 and NF-κB transcription factors. Proc. nat. Acad. Sci. (Wash.), (1996). (In press).
30. WAHL, C., MIETHKE, T., HEEG, K. and WAGNER, H., Clonal deletion as direct consequence of an in vivo T-cell response to bacterial superantigen. Europ. J. Immunol., 23, 1197-1200 (1993).
31. WHITE, J., HERMAN, A., PULLEN, A.M., KUBO, R., KAPPLER, J.W. and MARRACK, P., The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell, 56, 27-35 (1989).
32. WILLEMA, F., MARCHANT, A., DEVILLE, J.P., GÉRARD, C., DELVAUX, A., VELU, T., BOER, M. and GOLDMAN, M., Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Europ. J. Immunol., 24, 1007-1009 (1994).